Published in Int Arch Allergy Appl Immunol on January 01, 1975
Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release. Clin Exp Immunol (1978) 0.90
A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J Exp Med (1970) 2.15
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
Vi serology in detection of chronic Salmonella typhi carriers in an endemic area. Lancet (1983) 1.78
Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. J Exp Med (1980) 1.72
Dissociation of MIF production and cell proliferation. J Immunol (1972) 1.62
Low IgG2 and polysaccharide response in a T cell receptor expression defect. Eur J Immunol (1990) 1.43
On the number and nature of antigen-sensitive lymphocytes in the blood of delayed-hypersensitive human donors. J Exp Med (1971) 1.42
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma. J Immunol (1979) 1.33
Presensitization and kidney transplant failures. Postgrad Med J (1971) 1.33
Studies on the interactions between viruses and lymphocytes. Cold Spring Harb Symp Quant Biol (1977) 1.30
Killer immunoglobulin receptor gene and allele frequencies in Caucasoid, Oriental and Black populations from different continents. Tissue Antigens (2007) 1.15
Purification of human T and B cells by a discontinuous density gradient of percoll. J Immunol Methods (1979) 1.14
Migration inhibitory factor and the cellular basis of delayed-type hypersensitivity reactions. Am J Pathol (1970) 1.12
Pseudotumour cerebri with focal neurological deficit. J Neurol Neurosurg Psychiatry (1990) 1.12
Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell. Eur J Immunol (1976) 1.11
Intestinal intraepithelial lymphocytes contain a CD3- CD7+ subset expressing natural killer markers and a singular pattern of adhesion molecules. Scand J Immunol (2000) 1.11
The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet (2004) 1.09
Disorders of regulatory T cells in patients with selective IgA deficiency and its relationship to associated autoimmune phenomena. Clin Exp Immunol (1982) 1.09
Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections. Clin Transplant (2012) 1.06
Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T cell receptor). J Immunol (1993) 1.03
Bone marrow cells can give rise to ameloblast-like cells. J Dent Res (2006) 1.03
Cytotoxins in disease. V. Various diseases. Transplant Proc (1971) 1.03
{Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells. J Pharmacol Exp Ther (2010) 1.02
Origin of Mayans according to HLA genes and the uniqueness of Amerindians. Tissue Antigens (2003) 1.02
Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood (2001) 1.02
Complement receptor lymphocytes. Analysis of immunoglobin on their surface and further evidence of heterogeneity. Immunology (1975) 1.02
HLA-DR3, DR4 increase in chronic stage of Spanish oil disease. Lancet (1982) 1.02
Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression. J Immunol (1982) 1.00
Partial trisomy 6p: 46,XX, -10, der(10),t(6;10) (p22;q26)pat and HLA localisation. J Med Genet (1981) 0.99
HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing. Tissue Antigens (2004) 0.98
Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology (1997) 0.97
HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques, and Sardinians. Hum Genet (1981) 0.97
An in vivo functional immune system lacking polyclonal T-cell surface expression of the CD3/Ti(WT31) complex. Scand J Immunol (1987) 0.97
Familial C1q deficiency associated with renal and cutaneous disease. Clin Exp Immunol (1981) 0.97
Flow cytometry description of a novel CD3-/CD7+ intraepithelial lymphocyte subset in human duodenal biopsies: potential diagnostic value in coeliac disease. Cytometry (1998) 0.96
Rosette formation by mouse lymphocytes. IV. Fc and C3 receptors occurring together and separately on T cells and other leucocytes. Clin Exp Immunol (1975) 0.95
Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology (1998) 0.95
Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS. Neurology (2002) 0.95
Congenital T-cell receptor immunodeficiencies in man. Immunodefic Rev (1990) 0.94
In vivo activity of lymphokine-activated macrophages in host defense against neoplasia. J Immunol (1985) 0.94
Expression and function of a variant T cell receptor complex lacking CD3-gamma. J Exp Med (1991) 0.94
Alpha/beta heterodimeric T-cell receptor expression early in thymocyte differentiation. J Mol Cell Immunol (1988) 0.93
Familial defect in the surface expression of the T-cell receptor-CD3 complex. N Engl J Med (1988) 0.93
HLA genes in Arabic-speaking Moroccans: close relatedness to Berbers and Iberians. Tissue Antigens (2000) 0.93
Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells. Eur J Cancer (1974) 0.93
Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann N Y Acad Sci (2005) 0.93
Differential interleukin secretion by in vitro activated human CD45RA and CD45RO CD4+ T cell subsets. Cell Immunol (1992) 0.93
HLA-B73: an atypical HLA-B molecule carrying a Bw6-epitope motif variant and a B pocket identical to HLA-B27. Immunogenetics (1994) 0.93
Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol (2001) 0.92
High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. Tissue Antigens (2006) 0.92
Indication of hypoxic areas in tumours from in vivo NADH fluorescence. Eur J Cancer (1972) 0.91
The contribution of the HLA-A, -B, -C and -DR, -DQ DNA typing to the study of the origins of Spaniards and Basques. Tissue Antigens (1995) 0.91
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology (2002) 0.91
Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Eur J Immunol (1989) 0.90
Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release. Clin Exp Immunol (1978) 0.90
Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens (1997) 0.90
Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells. J Immunol (1982) 0.90
The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections. Transplant Proc (2007) 0.90
Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Methods (1983) 0.90
Autoimmune New Zealand mouse. Alterations in C3 receptors, complement-induced clumps and follicular adherence of immune complexes. Immunology (1975) 0.90
C3 receptor. A marker of a thymus-dependent B-cell subpopulation. Clin Exp Immunol (1975) 0.89
A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Immunogenetics (1997) 0.89
Contribution of NTRK2 to the genetic susceptibility to anorexia nervosa, harm avoidance and minimum body mass index. Mol Psychiatry (2005) 0.89
Stimulation of tumor-cell respiration by inhibitors of pyruvate kinase. Eur J Biochem (1975) 0.88
Cathepsin C gene: First compound heterozygous patient with Papillon-Lefèvre syndrome and a novel symptomless mutation. Hum Mutat (2001) 0.88
Polymorphism of the heat-shock protein gene HSP70-2 in systemic lupus erythematosus. Br J Rheumatol (1995) 0.88
HLA alleles in isolated populations from North Spain: origin of the Basques and the ancient Iberians. Tissue Antigens (2003) 0.88
Diffuse plasma cell infiltration of the small intestine with malabsorption associated to IgA monoclonal gammapathy. Cancer (1974) 0.88
Immunological findings in immunoblastic lymphadenopathy. A detailed case study. Clin Exp Immunol (1977) 0.88
A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin Diagn Lab Immunol (2001) 0.88
Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population. Diabetologia (1992) 0.87
A sensitive and reproducible method for the detection of oligoclonal IgM bands. J Immunol Methods (2001) 0.87
B cell hyperactivity and abnormalities in T cell markers and immunoregulatory function in a patient with nucleoside phosphorylase deficiency. Clin Exp Immunol (1982) 0.87
Allelic diversity at the primate Mhc-G locus: exon 3 bears stop codons in all Cercopithecinae sequences. Immunogenetics (1996) 0.87
Familial defect of CD3 (T3) expression by T cells associated with rare gut epithelial cell autoantibodies. Lancet (1986) 0.87
Inhibition of sodium-potassium-activated adenosine 5'-triphosphatase and ion transport by adriamycin. Cancer Res (1979) 0.86
Gut epithelial cell autoantibodies in AIDS pathogenesis. Lancet (1993) 0.86
Net movements of monovalent and bivalent cations, and their relation to energy metabolism, in slices of hepatoma 3924A and of a mammary tumour. Biochim Biophys Acta (1971) 0.85
In vitro immune cell function in six cases of immunoproliferative small intestinal disease after long term remission. Clin Exp Immunol (1983) 0.85
Lumphocytotoxins in leprosy. Int J Lepr Other Mycobact Dis (1976) 0.85
Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration. Clin Exp Immunol (1985) 0.85
Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet (1995) 0.85
Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement. Immunology (1975) 0.85
The Old World sparrows (genus Passer) phylogeography and their relative abundance of nuclear mtDNA pseudogenes. J Mol Evol (2001) 0.84
Competition for ADP between pyruvate kinase and mitochondrial oxidative phosphorylation as a control mechanism in glycolysis. Eur J Biochem (1974) 0.84
Mitochondrial functions in five cases of human neuromuscular disorders. J Neurol Neurosurg Psychiatry (1973) 0.84
Three new HLA-G alleles and their linkage disequilibria with HLA-A. Immunogenetics (1993) 0.84
Inhibition of the growth of ehrlich ascites tumors by treatment with the respiratory inhibitor rotenone. Eur J Cancer (1973) 0.83
Antibody-independent activation of complement by human peripheral B lymphocytes. Eur J Immunol (1979) 0.83
Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients. Transpl Infect Dis (2012) 0.83
Peripheral blood reduction of memory (CD29+, CD45RO+, and "bright" CD2+ and LFA-1+) T lymphocytes in Papillon-Lefèvre syndrome. Hum Immunol (1994) 0.83
HLA factors in non-insulin-dependent diabetes mellitus. N Engl J Med (1980) 0.83
Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome. Clin Exp Immunol (1984) 0.83
Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients. Clin Pharmacol Ther (2008) 0.83
Metabolic control of glycolysis in normal and tumor permeabilized cells. Cancer Res (1978) 0.83